The NHS Cheshire and Merseyside Area Prescribing Group (APG) and its subgroups provide a framework to coordinate the integration of safe, clinically effective and cost-effective medicines across Cheshire and Merseyside. Improved outcomes and an improved experience for patients are central to the decision-making process.  

The APG is a professional group consisting of GPs, pharmacists, and other key healthcare professionals who are responsible for ensuring robust standards and governance for decision-making.

  • Policies and Reports

    APG policy, APG terms of reference, Conflicts of interest, RAG definitions, Free-of-charge schemes, Out-of-area requests, Fast-track process, and NICE TA adherence.

  • APG subgroups

    New medicines, Formulary and guidelines, Interface prescribing, Safety, and Antimicrobial guide

  • Forms and applications

    New service developments, individual funding requests, and appeals process

  • Publications

    APG approvals report

  • Wegovy™ access in Cheshire and Merseyside

    Wegovy® (Semaglutide) – a weight-management treatment – is currently only available to NHS patients via specialist Tier 3 or 4 weight management services.

  • Valproate

    New regulatory measures for oversight of prescribing to new patients and existing female patients

  • Update on ADHD medication shortage

    We are providing an important update on the ongoing Attention Deficit Hyperactivity Disorder (ADHD) medication shortages affecting the UK. 


For medicines optimisation enquiries, please email: